Byondis B.v.

This is the first time a new drug called BYON4413 is being tested in people. The study aims to find a safe dose and see if it helps patients with acute myeloid leukemia or myelodysplastic syndromes that have returned or not responded to standard treatments. It will first test inc…

This is the first study in people testing a new immune-boosting drug called BYON4228, both alone and combined with an existing lymphoma drug (rituximab). It aims to find safe doses and see if it helps patients whose B-cell non-Hodgkin's lymphoma has returned or hasn't responded t…

This is an early-stage trial testing a new antibody drug called BYON4228, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. It is for patie…